Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery

被引:60
作者
Jamali, F [1 ]
Kunz-Dober, CM [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
关键词
pain relief; dental surgery; onset of analgesia; ibuprofen enantiomers; chiral inversion;
D O I
10.1046/j.1365-2125.1999.00902.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Rapid onset of analgesia is essential in the treatment of acute pain. There is evidence that conditions of stress cause delayed and decreased pain relief from oral analgesic products through impaired absorption. The aim was to determine the effect of surgery for removal of wisdom teeth on the plasma concentration-time profile of ibuprofen enantiomers. Methods Racemic ibuprofen, 200 mg in one group (n=7) and 600 mg in another group (n=7) was administered 1 week before (control) and again after (test) surgical removal of wisdom teeth. Serum concentrations of ibuprofen enantiomers were measured for 6 h. Results During: the control phase, S- and R-ibuprofen concentrations were within the suggested therapeutic range. Surgery resulted in a 2 h delay in the mean time to peak concentration, significant decreases in serum ibuprofen concentration following both doses, and a fall to sub-optimal serum concentrations following the 200 mg dose. During the first 2 h after the 200 mg dose, dental extraction resulted in a significant reduction of the area under serum drug concentration (AUC (0, 2 h) mg l(-1) h) from 5.6 +/- 2.9 to 1.6 +/- 1.8 (P< 0.01) and from 5.5 +/- 3.0 to 2.1 +/- 2.0 (P<0.05) for S and R-ibuprofen, respectively. Similar observations were made following the 600 mg dose for AUC (0, 2 h) of S-ibuprofen (from 14.2+/-6.1 to 7.2+/-5.5 mg l(-1) h, P<0.05) with no significant difference for R-ibuprofen (from 14.4+/-9.5 to 5.8+/-7.1). AUC (0, 6 h) was also significantly reduced by surgery. The pattern of stereoselectivity in serum ibuprofen concentration was reversed by surgery such that the S enantiomer was predominant in the control phase but not in the post-surgery phase, which is suggestive of reduced metabolic chiral inversion. Conclusions Surgery for wisdom tooth removal resulted in substantial decreases in the serum concentration of ibuprofen enantiomers and a prolongation in the time to peak concentration. Reduced absorption and altered metabolism are the likely cause of these changes. Thus, dental patients may experience a delayed response and possible treatment failure when taking ibuprofen for pain relief after surgery. Our observation may have implications for the treatment of other diseases.
引用
收藏
页码:391 / 396
页数:6
相关论文
共 19 条
[1]   STEREOCHEMICAL ASPECTS OF PHARMACOTHERAPY [J].
BROCKS, DR ;
JAMALI, F .
PHARMACOTHERAPY, 1995, 15 (05) :551-564
[2]   IS THE GUT AN ATHLETIC ORGAN - DIGESTION, ABSORPTION AND EXERCISE [J].
BROUNS, F ;
BECKERS, E .
SPORTS MEDICINE, 1993, 15 (04) :242-257
[3]   POSTOPERATIVE FATIGUE [J].
CHRISTENSEN, T ;
KEHLET, H .
WORLD JOURNAL OF SURGERY, 1993, 17 (02) :220-225
[4]  
FORBES JA, 1990, PHARMACOTHERAPY, V10, pS94
[5]   PICENADOL IN A LARGE MULTICENTER DENTAL PAIN STUDY [J].
GOLDSTEIN, DJ ;
BRUNELLE, RL ;
GEORGE, RE ;
COOPER, SA ;
DESJARDINS, PJ ;
GASTON, GW ;
JEFFERS, GE ;
GALLEGOS, LT ;
REYNOLDS, DC .
PHARMACOTHERAPY, 1994, 14 (01) :54-59
[6]   HUMAN PHARMACOKINETICS OF IBUPROFEN ENANTIOMERS FOLLOWING DIFFERENT DOSES AND FORMULATIONS - INTESTINAL CHIRAL INVERSION [J].
JAMALI, F ;
MEHVAR, R ;
RUSSELL, AS ;
SATTARI, S ;
YAKIMETS, WW ;
KOO, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (03) :221-225
[7]  
KIERSCH TA, 1993, CLIN THER, V15, P845
[8]   THE CORRELATION BETWEEN BLOOD-LEVELS OF IBUPROFEN AND CLINICAL ANALGESIC RESPONSE [J].
LASKA, EM ;
SUNSHINE, A ;
MARRERO, I ;
OLSON, N ;
SIEGEL, C ;
MCCORMICK, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (01) :1-7
[9]  
LEE EJD, 1985, BRIT J CLIN PHARMACO, V19, P669, DOI 10.1111/j.1365-2125.1985.tb02694.x
[10]   DISPOSITION OF IBUPROFEN IN PATIENTS WITH LIVER-CIRRHOSIS - STEREOCHEMICAL CONSIDERATIONS [J].
LI, GO ;
TREIBER, G ;
MAIER, K ;
WALKER, S ;
KLOTZ, U .
CLINICAL PHARMACOKINETICS, 1993, 25 (02) :154-163